Investigation of small animal tumor models in vivo using miniPET-scanner (P29) by Nagy, Tamás et al.
Abstracts
information which corresponds to a metabolic reaction, possibly in
relation with some aspect of the disease, and may contribute to better
define the status of the patient.
The PET/CT centre in Hápital Tenon, Paris is part of the Eu-
roNet-PHL-C1 study which has a different aim than our project. We
have the possibility to use a significant amou nt of multimodality data
has been gathered over 3 years. At the first step, we included 19
patients examined between October 2009 and December 2011. The
age range was 6-17 years. Ali patients had Hodgkin lymphoma. We
evaluated the baseline and interim FOG PET/CT (iPET) after 2 eyeles of
chemotherapy search ing for the next five "non-specilic" signs: dilfuse
uptake ol the bone marrow, of the thymus, ol the spleen, ol the spi nal
cord and activation of the brown fat. We made visual and semiquantita-
tive analysis (with SUVmax) ol "non-specific" uptakes. Based on clinical
data, we were looking lor correlation between any of the studied criteria,
the clinical particulars of the patient (e.g. inlection, inllammation, stress),
the final response to therapy and possible side effects.
Based on the visual interpretation of the "non-specific" uptakes we had
the lollowing results: diffuse thymus hyperactivity was detected in 16%
(3/19) at baseline and in only 5% (1/19) on the iPET;diffuse bone marrow
hyperactivity was detected in 37% (7/19) at baseline and in 16% (3/19)
on the iPET; diffuse spleen hyperactivity was detected in 48% (9/19) at
baseline and in 5% (1/19) on the iPET; diffuse spi nal cord hyperactivity
was detected in 31% (6/19) at baseline and in 16% (3/19) on the iPET;5%
(1/19) ol the patients had brown adipose tissue uptake on the baseline
and the iPET as weil. The semiquantitative analysis showed that there
is a signilicantly decreased uptake on the iPET in the case ol diffuse
spleen uptake and a significant increase ol diffuse liver uptake which
was measured as reference value. Regarding the relation between
"non-specilic" uptake and clinical follow-up data of the patient, we
are still gathering prospective data, these results are not yet available.
We have just provisional preliminary conclusions. Our results showed
that in paediatric Hodgkin lymphoma the dilluse spleen hyperactiva-
tion at baseline was more frequent than in adults, elevated diffuse
thymus uptake was not Irequent on the iPET and the liver uptake
was elevated after 2 eyeles ol treatment.
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Background: Presently in Hungary more than ninety live percent ol PET
scans are performed using 18F-Iluorodeoxyglucose (FDG) as the radio-
tracer. A wide range of can cer types are detectable with FOG, neverthe-
Iess in some malignancies the utility of FOG is limited. However, lor some
of these cases other agents are available, lor example 18F-DOPA for the
evaluation ol neurendocrine tumours. Neuroendocrine tissues have se-
veral common biochemical characteristics; they are ali have the capacity
to take up and decarboxylate amine precursors. These cells convert
18F-DOPA to 18F-dopamine by L-aminoacid-decarboxylase and store
the latter in their vesicies. Thus neuroendocrine tumours are detectable
by 18F-DOPA proportional to their decarboxylase content. Our objective
is to present our experience with the practical issues and evaluation of
paediatric 18F-DOPA scans.
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Material and methods: We have performed live PET/CT scans using
18F-DOPA radiotracer in children. The indications were restaging of
neuroblastoma in four cases and the exploration ol the diffuse or lo-
cal nature of the cause ol congenital hyperinsulinaemia in one case.
The injected 18F-DOPA activity was determined based on the EANM
recommendation, the tracer (IASOdopa) was from IASON GmbH
(Graz-Seiersberg, Austria). Additionally to the late (40-60 mins p.i.)
early static acquisitions (5 mins p.i.) were also performed, il abdominal
location ol the tumour was suspected. Emission data was acquired for
three minutes at each bed position using a Siemens Truepoint 6 HD
instrument; images were reconstructed by iterative algorithm.
Results and conclusions: Based on the small number ol cases it is not
possible to evaluate the uselulness ol 18F-DOPA scans in children.
However, we would like to discuss some important technical details and
evaluation issues ol paediatric 18F-DOPA scans.
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Background: Small animai PET technique is one ol the most sensi-
tive in vivo method for detection ol tumors and for the monitoring of
cancer therapy in preclinical studies. Earlier examinations showed, that
carbohydrate and amino acid metabolism in cancer cells are more
dynamic than in normal cells. The 18FDG (for the detection ol glucose
metabolism) and 11C-methionine (for the detect ion ol amino acid
transport and metabolism) are uselul PET radiotracers for the detection
ol primary tumors and metastases. Aims: In our research, the growing
ol primary tumors was monitored in rodent models with two PET tumor
diagnostic tracers using MiniPET-11scanner.
Material and methods: Myelomonocytic leukemia tumors (My1/De)
were induced in Long-Evans rats by subcutan injection and surgery
(implantation under the kidney capsule). The changes ol the intensity ol
tumor metabolism was followed by 18FDG and 11C-methionine using
small animai PET scanner (University of Debrecen, Department ol Nu-
clear Medicine). The recordings were evaluated with BrainCAD software.
The 18FDG and 11C-methionine uptake were expressed in terms ol
standardised uptake values (SUVs) and tumor to muscle (T/M) ratios.
Results: The subcutaneously injected and the surgically implanted
myelomonocytic sarcoma tumors showed an intensive growing, which
was manifested in the intensity ol glucose and amino acid metabolism
also. Five days after tumor cell implantation the primary tumor were
clearly detected by MiniPET-11scanner using the two tumor-diagnostic
tracers. The tracer accumulation and tumor growth was monitored lor 15
days. The increased accumulation ol radiotracers clearly demonstrated
the malignancy of tumors. During the test period necrotic areas were
not detectable in the experimental tumors.
Conclusion: Our results showed that 18FDG and 11C-methionine are
useful tumor-diagnostic tracers for monitoring the growing of implanted
tumors and the changes in metabolic processes in animai models. The
MiniPET-11scanner is a helplul appliance in the experimental cancer
research. With the help of this scanner, we can examine the physiologi-
cai and pathological process es in the living body using PET-Iabeled
molecules.
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